More information: Kai Chen et al, mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer, Cancer Research (2024). DOI: 10.1158/0008-5472.CAN-24-0984 ...

The malfunctioning mitochondria seem to poison the immune cells, explains Yosuke Togashi, a pulmonary physician and ...

Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation ...

GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...

Only dual route gene transfer therapy in development to treat Friedreich ... gene that disrupt production of the frataxin protein, a mitochondrial iron-binding protein involved in essential ...

is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and young adults. Using its gene therapy-based ...